[Effect of the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (acetazolamide) on citric acid excretion in the urine].
D000086:Acetazolamide / Q000494:pharmacology*; D001826:Body Fluids; D002257:Carbonic Anhydrase Inhibitors; D002951:Citrates / Q000652:urine*; D019343:Citric Acid; D006801:Humans; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D013830:Thiadiazoles
D002257:Carbonic Anhydrase Inhibitors; D002951:Citrates; D013424:Sulfanilamides; D013449:Sulfonamides; D013830:Thiadiazoles; C058949:1,3,4-thiadiazole; D000077145:Sulfanilamide; D019343:Citric Acid; D000086:Acetazolamide
ACETAZOLAMIDE/effects; CITRATES/in urine
Uber den Einfluss des Carboanhydrasehemmstoffes 2-Acetylamino-1,3,4-Thiadiazol-5-Sulfonamid (Acetazolamid) auf die Citronensăureausscheidung im Harn.